The U.S. Food and Drug Administration (FDA) today continued to take action in the ongoing response to the COVID-19 pandemic:
- Today, the FDA updated the Testing Supply Substitution Strategies slide show. This presentation includes validated supply alternatives that labs can use to continue performing testing when there is a supply issue with some components of a molecular test. Download the 1.5MB PowerPoint slide show file and click Slide Show > From Beginning.
- This week, FDA and the Federal Trade Commission issued a joint warning letter to 21st Century LaserMed Pain & Regenerative Medicine Institute (d/b/a Create Wellness Clinics) for offering unapproved, unlicensed, uncleared and unauthorized products for the mitigation, prevention, treatment, diagnosis or cure of COVID-19. There are currently no FDA-approved products to prevent or treat COVID-19. Consumers concerned about COVID-19 should consult with their health care provider.
- Testing updates:
- To date, the FDA has currently authorized 187 tests under EUAs; these include 154 molecular tests, 31 antibody tests, and 2 antigen tests.
|
|
|
|
No hay comentarios:
Publicar un comentario